Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 7, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, April 7, 2025 -- Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, according to a study published online April 1 in JAMA Network Open.

Diya Surie, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined characteristics associated with RSV vaccine receipt and knowledge and attitudes relating to RSV vaccines during the first season of RSV vaccine use from Oct. 1, 2023, to April 30, 2024, among adults aged 60 years or older hospitalized with RSV-negative acute respiratory illness.

Of the 6,746 hospitalized adults aged 60 years or older, 10.4 and 89.6 percent were RSV-vaccinated and unvaccinated, respectively. The researchers found that 47.2 percent of the 3,219 unvaccinated adults who responded to RSV knowledge questions had not heard of RSV or were unsure; 78.5 percent were unsure if they were eligible for vaccination or thought they were not. Characteristics associated with RSV vaccination were age 75 years or older and being male (adjusted risk ratios [aRRs], 1.23 and 1.15, respectively), having pulmonary disease and immunocompromised status (aRRs, 1.39 and 1.30, respectively), low or moderate social vulnerability index (aRR, 1.47 for both), and educational level consisting of four or more years of college, at least some college or technical training, or grade 12 or General Education Development (aRR, 2.91, 1.85, and 1.44, respectively) in adjusted analyses. Residents of long-term care facilities, patients with Medicaid coverage, and uninsured patients were less likely to have RSV vaccination.

"Ongoing monitoring in future RSV seasons is needed to determine whether simplified recommendations, increases in awareness of RSV disease and vaccine information, and expansion in access to primary prevention services will lead to improved RSV vaccination coverage among older adults at higher risk for severe disease," the authors write.

Several authors disclosed ties to the biopharmaceutical industry; two authors disclosed holding relevant patents.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-08 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords